Prior authorization and the WISeR model: gold-carding, denials, and the appeal path after a non-affirmation.
WISeR is not just another prior-auth queue with a new logo. It routes through six private technology companies under CMS contract, not your MAC directly, and a non-affirmation from one of them can't be appealed at all — only the claim denial that follows it can. This guide goes past the headline mechanics to the parts that actually change a Monday workflow: which company reviews your state's requests, the exact numbers that earn a gold-carding exemption, and the full appeal ladder — with 2026's filing deadlines and dollar thresholds — once a claim denies after a non-affirmation.
Key takeaways
- Each of the six pilot states routes to a different named model participant, not the MAC itself. Two states can share a MAC jurisdiction and still answer to two different reviewers with two different portals.
- Gold-carding is a specific, checkable number: 10+ requests and a 90% affirmation rate, re-evaluated quarterly — not a vague reward for "good documentation."
- A non-affirmation is a dead end by itself, but the claim that follows it isn't — it opens the standard five-level Medicare appeal ladder, each level with its own filing clock.
- An affirmation is not a payment guarantee. Mid-2026 reporting documents affirmed WISeR requests still denied at the claim stage — keep monitoring the claim after the prior auth clears.
Who actually reviews the request, state by state
WISeR requests don't land on a MAC's desk first. CMS contracted six technology companies as "model participants," and each owns a specific state's reviews, with its own portal and peer-to-peer scheduling process. A biller used to a MAC's provider portal shouldn't assume a WISeR request follows the same login — it doesn't.
| State | MAC / jurisdiction | Model participant |
|---|---|---|
| Arizona | Noridian — JF | Zyter Inc. |
| Washington | Noridian — JF | Virtix Health LLC |
| New Jersey | Novitas — JL | Genzeon Corporation |
| Ohio | CGS — J15 | Innovaccer Inc. |
| Oklahoma | Novitas — JH | Humata Health, Inc. |
| Texas | Novitas — JH | Cohere Health, Inc. |
Notice that Oklahoma and Texas share a MAC jurisdiction (JH, Novitas) but answer to two different model participants — Humata Health and Cohere Health, respectively. A multi-location practice billing in both states needs two separate portal registrations, not one shared assumption about "how JH handles WISeR." Scope hasn't changed from the rest of our pain management guide: CPT 62323 is the only interventional pain code in the model, and facet injections, MBBs, and RFA remain outside it.
The gold-carding exemption, in the numbers that matter
CMS built an exemption path into WISeR, and it's a concrete number, not a subjective review of reputation. A provider or supplier earns gold-card status — exemption from ongoing prior authorization and pre-payment review for that service — by submitting at least 10 requests during the assessment period and clearing at least 90% of them with an affirmation, while carrying no active Medicare exclusion.
- 1Minimum volume: 10 requests. A low-volume practice billing 62323 only a handful of times a year may never accumulate enough in one window to qualify, independent of documentation quality.
- 2Ceiling, not a fixed bar: 90% affirmation. Model participants can set their own qualifying threshold lower, but CMS caps it there — none can demand a higher rate.
- 3Exemptions last at least one year, reassessed quarterly. A practice that qualifies still needs to keep submitting clean requests to stay off the review list at the next check.
- 4Rollout is staggered. CMS began gold-carding in Washington state, with the other five pilot states following on a quarterly schedule — confirm your state's program is live before building a workflow around it.
Track your practice's own WISeR affirmation rate for 62323 every quarter, the same way you'd track a denial rate, and treat 90% as the number to beat. A practice already running clean epidural documentation for MAC LCD purposes — region-specific diagnosis, dated conservative-care trial, current imaging — is most of the way to the same packet WISeR wants; gold-carding rewards a documentation habit the practice should already have, not a separate one.
What happens after a non-affirmation: the appeal ladder that actually applies
The WISeR non-affirmation decision itself has no reconsideration path — that part of the model is final. What changes the outcome is proceeding anyway: perform the service, submit the claim to the MAC, and let the MAC issue its own initial determination. That determination is a standard Medicare claim decision, carrying the full five-level administrative appeal process, each level with its own filing window and decision clock.
| Level | File within | Decision due | 2026 dollar threshold |
|---|---|---|---|
| 1. Redetermination (MAC) | 120 days of the initial determination | 60 days after the MAC receives it | None |
| 2. Reconsideration (QIC) | 180 days of the redetermination | 60 days after the QIC receives it | None |
| 3. ALJ hearing (OMHA) | 60 days of the reconsideration | 90 days after OMHA receives it | $200 amount in controversy |
| 4. Medicare Appeals Council | 60 days of the ALJ decision | 90 days after the Council receives it | None |
| 5. Federal district court | 60 days of the Council decision | — | $1,960 amount in controversy |
Those dollar thresholds move every calendar year with a CMS inflation adjustment, so don't carry last year's figures into a new appeal without checking. A practice that treats a non-affirmed 62323 request as fully closed is walking away from a live appeal path with a defined timeline — the mistake isn't losing the appeal, it's never filing the redetermination request within 120 days because front-desk staff logged the non-affirmation itself as final.
One gap worth naming: mid-2026 reporting from the pilot states documents cases where a request was affirmed and the claim still denied at payment. An affirmation is not a payment guarantee — keep the claim on the normal AR worklist after a WISeR affirmation clears rather than treating it as the end of that claim's revenue-cycle journey.
Peer-to-peer scheduling for WISeR has run rough in 2026 — providers report waits as long as 90 minutes just to get a call scheduled, with the conversation itself happening a week or more later. Assign one staff member to own peer-to-peer requests, keep the documentation packet assembled before the call is requested, and build that one-to-two-week gap into scheduling instead of booking the procedure and hoping it resolves in time.
The submission packet that clears review the first time
Every model participant is reviewing against the same underlying medical-necessity question, so the packet that avoids a peer-to-peer looks the same regardless of which of the six companies is on the other end.
- 1Current imaging report, cited by date and finding — the specific level and side matching the injection requested, not a general "MRI on file" note.
- 2Region-specific diagnosis code, such as M54.16 (lumbar radiculopathy) or M54.17 (lumbosacral radiculopathy), pulled from the imaging report rather than an unspecified EHR default.
- 3Conservative care trial with dates and modality — physical therapy, oral medication, or activity modification, with a start date and an end date or documented ongoing status.
- 4Objective response data from any prior injection at the same level — a numeric pain-scale change and duration of relief, not "patient reported improvement." This is the single most common gap that triggers a peer-to-peer.
- 5Submitted through the correct model participant's portal, with staff already registered, and enough lead time that the 120-day affirmation window and the procedure date don't collide.
Do and don't
- Confirm which model participant covers each state your practice bills 62323 in, and register staff on that specific portal ahead of the first request.
- Track your own WISeR affirmation rate quarterly against the 90% gold-carding line, the same way you'd track a denial rate.
- File a redetermination request within 120 days of any claim denial that follows a non-affirmation — don't log a non-affirmation itself as a closed file.
- Keep a WISeR-affirmed claim on the normal AR worklist until it actually pays.
- Don't try to appeal the non-affirmation decision itself — there's no path for that; the appeal targets the claim denial that follows.
- Don't assume a shared MAC jurisdiction means a shared model participant or portal — Oklahoma and Texas prove otherwise.
- Don't submit a request with "improvement reported" instead of a numeric pain-scale change and duration — that gap is the most common trigger for a peer-to-peer.
- Don't schedule a procedure on a timeline that assumes the peer-to-peer will resolve within days — current reporting shows it often doesn't.
Getting caught out by WISeR non-affirmations?
We'll review your practice's WISeR submission history, confirm you're registered with the right model participant, and build the appeal-tracking workflow so a non-affirmation never gets logged as a dead end by mistake.
Frequently asked questions
What actually happens if a WISeR prior authorization request comes back non-affirmed?
The non-affirmation decision itself cannot be appealed — there's no reconsideration path against it. But the practice can still proceed with the service and submit the claim to the MAC, and the MAC's resulting payment decision is a standard initial determination that carries full Medicare appeal rights: redetermination, QIC reconsideration, an ALJ hearing, Medicare Appeals Council review, and federal court, in that order. The thing you're appealing is never the WISeR decision — it's the claim denial that follows it.
How does a pain management practice qualify for the WISeR gold-carding exemption?
A provider or supplier needs at least 10 prior authorization requests for a WISeR-covered service during the assessment period and an affirmation rate of at least 90% on those requests, with no active exclusion from Medicare. CMS lets individual model participants set the bar lower than 90% but not higher. Exemptions last at least one year once granted and are re-evaluated quarterly, so a practice that qualifies still needs to keep its documentation habits consistent to keep the exemption at the next review.
Does WISeR prior authorization cover facet injections, medial branch blocks, or RFA?
No. As of this build, WISeR's interventional-pain scope in the six pilot states is limited to CPT 62323, the lumbar or sacral interlaminar epidural steroid injection. Facet joint injections, medial branch blocks, and radiofrequency ablation are not on the model's current service list. CMS can expand that list without much advance notice, so re-check the current WISeR service list before assuming any other pain procedure is out of scope, especially if your practice bills across more than one of the six states.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.